Healthcare & Life Sciences
Exo Therapeutics
United Statesexo-therapeutics.com
Exo Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Exo Therapeutics
Based in the United States, Exo Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Exo Therapeutics is a small molecule drug discovery and development company using a proprietary platform to identify and develop inhibitors that target enzyme exosites for oncology and inflammatory diseases.
Explore Exo Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.